Karima Redouan
Family · Clearwater, FLNPI 1770090623
Payments from drug & device makers
Across 86 payments — averaging $106.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Abbott$764
- Novo Nordisk$547
- Dexcom, Inc.$535
- AstraZeneca$514
- Abiomed$502
- plus $5K from 28 others
What the payments were for
- Food & beverage$9,183100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $1,370 |
| Abbott | 7 | $764 |
| Novo Nordisk | 5 | $547 |
| Dexcom, Inc. | 4 | $535 |
| AstraZeneca | 5 | $514 |
| Abiomed | 5 | $502 |
| Actelion Pharmaceuticals US, Inc. | 4 | $476 |
| Neurocrine Biosciences, Inc. | 3 | $373 |
| Amgen | 3 | $353 |
| Sanofi | 3 | $324 |
| Corcept Therapeutics | 2 | $250 |
| Bayer | 3 | $235 |
| Insmed, Inc. | 2 | $211 |
| GSK | 2 | $210 |
| Sanofi-aventis U.S. LLC | 2 | $206 |
| Biohaven Pharmaceuticals, Inc. | 2 | $198 |
| Arcutis Biotherapeutics, Inc. | 2 | $186 |
| Idorsia Pharmaceuticals US Inc | 3 | $166 |
| Cvrx, Inc. | 1 | $138 |
| Teva Pharmaceuticals USA, Inc. | 1 | $133 |
| Boston Scientific | 1 | $129 |
| Verrica Pharmaceuticals Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $122 |
| Axonics, Inc. | 2 | $118 |
| Argenx US, Inc. | 1 | $116 |
| Alkermes, Inc. | 1 | $115 |
| Paratek Pharmaceuticals, Inc. | 1 | $114 |
| Sanofi Pasteur Inc. | 1 | $103 |
| Gilead | 1 | $103 |
| Boehringer Ingelheim | 1 | $101 |
| Lucid Diagnostics Inc. | 1 | $100 |
| Johnson & Johnson | 1 | $90 |
| Medtronic | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G7 GSS (161)$535
- VRAYLAR$473
- LYBALVI$459
- UPTRAVI$393
- OPSUMIT$393
- FREESTYLE LIBRE 3$376
- INGREZZA$373
- DEXCOM STELO GLUCOSE BIOSENSOR$280
- Korlym$250
- UBRELVY$243
- Ozempic$241
- QULIPTA$236
- Impella$216
- Arikayce$211
- Wegovy$203
- FreeStyle Libre 2$145
- Barostim Neo System$138
- Austedo XR$133
- WATCHMAN FLX$129
- YCANTH$125
How this compares
$9,183 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other family in Clearwater
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.